STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] ABBOTT LABORATORIES Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Patricia Paola Gonzalez, a director of Abbott Laboratories (ABT), had a non-derivative transaction on 09/30/2025 that credited 246 stock equivalent units at an indicated per-share reference of $133.94. After the reported transaction, the filing shows she beneficially owned 4,922 shares/stock-equivalent units. The filing explains these credits represent director fees placed into a stock equivalent unit account under a director grantor trust, which are paid in cash generally at age 65 or upon retirement from the board and earn the same return as if invested in Abbott shares. The reported Form 4 was signed via attorney-in-fact on 10/02/2025.

Positive
  • Director compensation is tied to stock-equivalent units, aligning pay with shareholder returns
  • Dividend reinvestment feature is active, as balance includes units from dividends
Negative
  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Gonzalez Patricia Paola

(Last) (First) (Middle)
100 ABBOTT PARK ROAD

(Street)
ABBOTT PARK IL 60064

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ABBOTT LABORATORIES [ ABT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
09/30/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Equivalent Units (1) 09/30/2025 A 246 (1) (1) Common Shares 246 $133.94 4,922(2) D
Explanation of Responses:
1. Director fees credited to a stock equivalent unit account under a grantor trust established by the director and paid, in cash, generally at age 65 or upon retirement from the board. The stock equivalent units earn the same return as if the fees were invested in Abbott shares.
2. Balance includes stock equivalent units acquired pursuant to a dividend reinvestment feature.
/s/ Patricia Paola Gonzalez by Jessica H. Paik, Attorney-in-Fact 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Abbott director Patricia Gonzalez report on Form 4 (ABT)?

The Form 4 reports a 09/30/2025 credit of 246 stock equivalent units at a reference of $133.94 and a post-transaction beneficial ownership of 4,922 units.

How are the stock equivalent units for the director paid or settled?

The filing states director fees are credited to a stock equivalent unit account under a grantor trust and are paid in cash generally at age 65 or upon retirement from the board.

Do the stock equivalent units earn returns like Abbott shares?

Yes, the Form 4 explains the stock equivalent units earn the same return as if the fees were invested in Abbott shares.

Does the reported balance include dividend reinvestment?

Yes. The filing notes the balance of 4,922 includes stock equivalent units acquired pursuant to a dividend reinvestment feature.

When was the Form 4 signed and who signed it?

The Form 4 was signed on behalf of Patricia Paola Gonzalez by an attorney-in-fact, with the signature dated 10/02/2025.
Abbott Labs

NYSE:ABT

ABT Rankings

ABT Latest News

ABT Latest SEC Filings

ABT Stock Data

226.11B
1.73B
0.54%
80.8%
1.02%
Medical Devices
Pharmaceutical Preparations
Link
United States
ABBOTT PARK